Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 135 News Items found In the Clinic How Robotic Surgery for Colorectal Cancer Can Reduce Side Effects Thursday, March 14, 2024 MSK performs the highest number of robot-assisted surgeries for colorectal cancer in the United States, enabling more patients to have a shorter hospital stay and a faster recovery. Treating HER2-Amplified Early-Stage Rectal Cancer To Improve Quality of Life Saturday, April 18, 2026 Learn how rectal cancer patients with HER2 driven tumors benefited from an early stage clinical trial at MSK. In the Lab Manipulating a Single Gene Turns Colorectal Cancer Cells Back to Normal Wednesday, July 1, 2015 For the first time, scientists have shown that the gene APC, which is mutated in the vast majority of colorectal cancers, might be a promising target for future therapies. You’ve Finished Cancer Treatment. Now What? MSK’s Survivorship Program Provides Expert Care Monday, June 14, 2021 Meet Christopher Jeter, who was diagnosed nearly 10 years ago with lung cancer. He was successfully treated at Memorial Sloan Kettering and now is being closely monitored by experts in MSK's Adult Survivorship Program. The Rectal Cancer Clinical Trial at MSK That Changed Everything for Its Patients Wednesday, August 16, 2023 Learn how a heralded clinical trial that made rectal cancer disappear for every participant is being expanded at Memorial Sloan Kettering Cancer Center. The trial uses only immunotherapy that targets a rare mutation — without the need for surgery, chemotherapy, or radiation. Ask the Expert Should I Drink Coffee to Prevent Colorectal Cancer? Friday, March 22, 2019 Recent studies have raised the possibility that coffee might protect against colorectal cancer. MSK surgeon Garrett Nash advises against jumping to conclusions. Genetic Information Becomes a Vital Part of Clinical Practice Wednesday, October 1, 2008 At Memorial Sloan Kettering, as the genetics revolution continues to flourish, discoveries made in the laboratory are increasingly producing real-world benefits for cancer patients. Science Byte Blocking Enzymes That Signal DNA Damage Could Be a Treatment Strategy for Childhood Cancers Wednesday, November 1, 2017 A new strategy for treating pediatric cancers involves preventing cells from repairing their own DNA. The Fiona and Stanley Druckenmiller Center for Lung Cancer Research: Blazing New Paths Toward Lung Cancer Treatments Thursday, October 1, 2020 Learn about the goals of the Fiona and Stanley Druckenmiller Center for Lung Cancer Research: to reveal more about the biology of lung cancer, to examine novel treatment approaches, and to bring promising new therapies to our patients. Black Men and Women Are at Higher Risk of Colorectal Cancer: What You Should Know Friday, June 4, 2021 Black adults are more likely to get colorectal cancer and die from it than any other group. Learn how Black men and women can protect themselves and why screening for colorectal cancer beginning at age 45 is so important. Pagination First page « First Previous page ‹ Previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page Next › Last page Last » Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment